Santos Muscle Nutrition, a Netherlands-based sports nutrition brand, announced its participation in the ECRM Vitamin, Weight Management & Sports Nutrition Session, scheduled for September 14-17, 2026, in Palm Beach Gardens, Florida. The event is designed to connect emerging wellness brands with leading health, specialty, food, drug, and mass retailers seeking new distribution opportunities in the U.S. market.
"Our participation in ECRM represents an important milestone in our U.S. expansion strategy," said Mike de Groot, Founder of Santos Muscle Nutrition. "We're excited to introduce Santos Muscle Nutrition to major retail buyers and demonstrate the quality and performance standards behind our products."
Founded in the Netherlands, Santos Muscle Nutrition develops products aimed at supporting active individuals at every stage of their fitness journey. The company's portfolio includes whey protein, creatine monohydrate, pre-workout supplements, and additional performance nutrition products under development. The brand emphasizes quality, consistency, and practical performance as it continues international expansion, particularly in the United States.
The ECRM session offers Santos Muscle Nutrition direct meetings with category buyers responsible for evaluating new products for placement across multiple retail channels. With growing consumer demand for sports nutrition, the company believes its European heritage and performance-focused formulations position it well for continued growth.
"We believe American consumers are looking for brands they can trust," de Groot added. "Our goal is to build long-term retail partnerships while introducing more athletes and active consumers to Santos Muscle Nutrition."
Santos Muscle Nutrition recently launched its first products for U.S. consumers through OneLavi, marking its initial retail expansion into the American market. Available products include Santos Muscle Nutrition Cookies & Cream Whey Protein (900g), Pre-Workout in Bubblegum flavor, and Creatine Monohydrate. Additional availability through Amazon and Walmart.com is expected as the company executes its U.S. growth strategy.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
